Organigram Holdings Inc. Consolidated Net Income/Loss

Consolidated Net Income/Loss of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Consolidated Net Income/Loss growth rates and interactive chart.


Highlights and Quick Summary

  • Consolidated Net Income/Loss for the quarter ending August 31, 2022 was $-4.81 Million (a 119.37% increase compared to previous quarter)
  • Year-over-year quarterly Consolidated Net Income/Loss increased by 372.19%
  • Annual Consolidated Net Income/Loss for 2022 was $-11.2 Million (a -89.17% decrease from previous year)
  • Annual Consolidated Net Income/Loss for 2021 was $-104 Million (a -0.2% decrease from previous year)
  • Annual Consolidated Net Income/Loss for 2020 was $-104 Million (a 1354.5% increase from previous year)
  • Twelve month Consolidated Net Income/Loss ending August 31, 2022 was $-11.2 Million (a -58.48% decrease compared to previous quarter)
  • Twelve month trailing Consolidated Net Income/Loss decreased by -85.44% year-over-year
Trailing Consolidated Net Income/Loss for the last four month:
31 Aug '22 31 May '22 28 Feb '22 30 Nov '21
$-11.2 Million $-27 Million $-28.1 Million $-77 Million
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Consolidated Net Income/Loss of Organigram Holdings Inc.

Most recent Consolidated Net Income/Lossof OGI including historical data for past 10 years.

Interactive Chart of Consolidated Net Income/Loss of Organigram Holdings Inc.

Organigram Holdings Inc. Consolidated Net Income/Loss for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-4.81 $-2.19 $-3.19 $-11.23
2021 $-1.02 $-20.61 $-3.31 $-52.09 $-103.73
2020 $-26.08 $-31.14 $-64.31 $-5.19 $-103.94
2019 $-0.65 $-17.34 $-7.59 $-4.79 $-7.15
2018 $22.53 $14.17 $17.02
2017 $-8.51
2016 $0.65

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic